Coughing Again? It Could be More Than a Cold Chicago, IL,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Coughing Again? It Could be More Than a Cold

Chicago, IL, Jan. 8, 2014 (GLOBE NEWSWIRE) -- It's that time of year again. Right after New Year's when the temperature seems to drop as low as it can go, like clockwork, your annual winter cough returns. Each year you suffer through the cough spells, sore throat, and chronic throat clearing , futilely treating your "winter cold" with cough syrup and endless throat lozenges.

http://www.globenewswire.com/newsroom/prs/?pkgid=17319

According to Chicago allergist and chronic cough specialist, Brian Rotskoff, MD, there may be a very simple reason why your cold medicine isn't making a dent in your cough. As an expert in chronic cough, he knows that a chronic cough is rarely caused by a simple cold. With increasing prevalence, Dr. Rotskoff is seeing patients from around the country who are suffering from more complex cough conditions such as cough receptor hypersensitivity syndrome, or laryngeal sensory neuropathy (LSN).

"Rarely is a cough just a cough," explains Dr. Rotskoff. "It's usually indicative of something else going on in the body. We all have a cough threshold that, if crossed, will trigger a cough. People with cough receptor hypersensitivity syndrome [or LSN] have a significantly lower cough threshold."

A 3-in-1 approach to chronic cough

The three most common causes of chronic cough are acid reflux, asthma, and post-nasal drip . When diagnosing the cause of your symptoms, these three factors need to be taken into account. "It's sort of a 3-in-1 approach," explains Dr. Rotskoff.

When a patient comes to Clarity Allergy Center in Chicago complaining of chronic cough, chronic throat clearing, or hoarseness, Dr. Rotskoff examines the overall health of that patient. Taking on the perspective of a gastroenterologist looking for acid reflux, an ENT doctor examining the affected larynx and voice box, an allergist diagnosing allergies, or a pulmonologist treating asthma, Dr. Rotskoff explores all the possible triggers of cough.        

"As a doctor, my number one focus is the health of my patients," says Dr. Rotskoff. "Even though I specialize in treating breathing, sinus, and allergy conditions, I examine my patients as a whole. Everything in the human body is interrelated, like a cause-and-effect puzzle. My job is to connect the two."  

Which symptom first?

"You can have a combination of things that could be triggering the cough at one time," explains Dr. Rotskoff. "For example, asthma may trigger the cough during one episode. Another episode could be mainly acid reflux. But until you treat the cough hypersensitivity disorder, no other treatments will work."

Because cough is the primary condition, Dr. Rotskoff will prescribe a neuropathic medication to "turn off" the cough reflex. From there, he can isolate each cough trigger and tailor treatment.

If it's not post-nasal drip, asthma, or acid reflux...

Acid reflux is a major contributor to cough receptor hypersensitivity syndrome, even though it is sometimes harder to find. Silent reflux, or laryngopharyngeal reflux (LPR), is a condition in which stomach acid backs up into the throat (pharynx) or voice box (larynx) and pools in the nasal airways. For those with silent reflux, the signs of acid are almost undetectable, but chronic cough, hoarseness, chronic throat clearing, post-nasal drip, sore throat, and trouble swallowing are all symptoms of the disorder.

You may not have realized it over the holidays, but indulging in the rich foods and drinks aggravates your stomach acid and pushes you to the edge of your cough threshold.

How to treat silent reflux

If stomach acid is the cause of your chronic cough, you may already be on the right track for treatment. Dr. Rotskoff advises certain New Year's resolution-esque changes, such as losing weight, quitting smoking, avoiding alcohol, and removing certain foods from your diet to minimize acid.

Add seeing Dr. Rotskoff to your list of New Year's resolutions. Getting to the bottom of what is making you cough, can change your whole outlook for 2014.  

Clarity Allergy Center Dr. Brian Rotskoff, MD T: 773-877-3500 Web: http://www.clarityallergycenter.com/ North Chicago Office 4801 W. Peterson Avenue, Suite 306 Chicago, IL 60646 Chicago Office 3000 N. Halsted St, Suite 611 Chicago, IL 60657 Arlington Heights Office 125 South Wilke Road, Suite 100 Arlington Heights, IL 60005 http://www.clarityallergycenter.com/contact/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading